Eric and Sally’s Story Understanding the CAR T Experience

Eric, a patient with multiple myeloma, and Sally, his wife and care partner, share their journey with chimeric antigen receptor T-cell (CAR T) therapy, from infusion to post-treatment recovery. They discuss how they navigated the monitoring and treatment of adverse effects. Furthermore, Sally highlights the importance of clear communication with the healthcare team during the recovery process.

MORE TREATMENT PERSPECTIVES IN MULTIPLE MYELOMA:

Eric and Sally’s Story From Diagnosis to CAR T

Eric, his wife and care partner Sally, and Eric’s oncologist, Omar Castaneda Puglianini, MD, discuss Eric’s multiple myeloma diagnosis and treatment journey. Upon his first relapse, he decided that CAR T therapy was right for him, as he wanted to maintain his active lifestyle. Eric and Sally also describe the support they’ve received from their healthcare team throughout the course of treatment. Additionally, Dr. Castaneda Puglianini clears up some misconceptions about CAR T therapy, such as concerns related to patient eligibility and post-treatment recovery.

Spotlight on CAR-T Care Partners

Tony and his best friend, Michael, discuss Tony’s journey with CAR-T therapy and the network of care partners who provided support during his journey. Michael and Tony share wisdom on identifying care partners within your support network, as well as helpful financial resources for CAR-T recipients and their care partners to aid them in their journey.

Tony’s Journey After CAR-T

Hear Tony’s experience recovering after CAR-T therapy for multiple myeloma and learn about financial and travel resources that may support treatment.

©2026 Oncology Matrix. All Rights Reserved.